Page last updated: 2024-10-17

cytosine and Body Weight

cytosine has been researched along with Body Weight in 32 studies

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"Aiming to characterize the effects of nutritional status on epigenetic markers, such as DNA 5-methyl cytosine (mC) methylation and RNA N6-methyladenosine (m6A) methylation, of bovine sperm, 12 Angus × Hereford crossbred breeding bulls were submitted to nutritional changes for a period of 180 d: no change in body weight (BW) (phase 1 = 12 d), BW loss (phase 2 = 78 d), and BW gain (phase 3 = 90 d) in a repeated measures design."8.12Sperm DNA 5-methyl cytosine and RNA N6-methyladenosine methylation are differently affected during periods of body weight losses and body weight gain of young and mature breeding bulls. ( Archilia, EC; Batalha, IM; Fonseca, MA; Macias-Franco, A; Moreira, GM; Moura, FH; Norris, AB; Pena-Bello, CA; Schütz, LF; Silva, AEM, 2022)
"Aiming to characterize the effects of nutritional status on epigenetic markers, such as DNA 5-methyl cytosine (mC) methylation and RNA N6-methyladenosine (m6A) methylation, of bovine sperm, 12 Angus × Hereford crossbred breeding bulls were submitted to nutritional changes for a period of 180 d: no change in body weight (BW) (phase 1 = 12 d), BW loss (phase 2 = 78 d), and BW gain (phase 3 = 90 d) in a repeated measures design."4.12Sperm DNA 5-methyl cytosine and RNA N6-methyladenosine methylation are differently affected during periods of body weight losses and body weight gain of young and mature breeding bulls. ( Archilia, EC; Batalha, IM; Fonseca, MA; Macias-Franco, A; Moreira, GM; Moura, FH; Norris, AB; Pena-Bello, CA; Schütz, LF; Silva, AEM, 2022)
" The purpose of this study is to study potential biomarkers used for monitoring the toxic effects after chronic exposure to ATR by studying urine metabolites."1.48Potential biomarkers for monitoring the toxicity of long-term exposure to atrazine in rat by metabonomic analysis. ( Geng, TQ; Li, LX; Zhang, CH; Zhang, XF; Zhang, Y; Zheng, J, 2018)
"To model adenovirus infections in immunocompromised humans, we examined ganciclovir's efficacy in immunosuppressed Syrian hamsters intravenously infected with type 5 human adenovirus (Ad5)."1.40Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters. ( Balakrishnan, L; Buller, RM; Capella, C; Dewhurst, S; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B, 2014)
"Bladder cancer is highly recurrent after intravesical therapy, and most of the deaths from this disease are due to invasive metastasis."1.38Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice. ( Chen, SS; Huang, CC; Lin, PY; Lin, YL; Liu, YW, 2012)
"Gemcitabine was used as a positive control."1.31The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. ( Jolivet, J; Locas, C; Marty, J; Von Hoff, DD; Weitman, S, 2000)
"Bropirimine is an immunomodulator with experimental antiviral and antitumor activities."1.28Reversal of bropirimine developmental toxicity with progesterone. ( Black, DL; Branstetter, DG; Kirton, KT; Marks, TA, 1991)
"Oral bropirimine (an immunomodulator shown to induce interferon) was administered to timed-pregnant Sprague-Dawley rats in five experiments utilizing several different dosing schedules."1.28Bropirimine-induced embryolethality after oral administration to the pregnant rat. ( Marks, TA; Poppe, SM; Renis, HE, 1989)
" This effect and the fact that all three doses were toxic to the dams dictated that a second experiment be carried out at lower doses."1.27Developmental toxicity of bropirimine in rats after oral administration. ( Marks, TA; Poppe, SM, 1988)

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19906 (18.75)18.7374
1990's4 (12.50)18.2507
2000's14 (43.75)29.6817
2010's7 (21.88)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Moura, FH1
Macias-Franco, A1
Pena-Bello, CA1
Archilia, EC1
Batalha, IM1
Silva, AEM1
Moreira, GM1
Norris, AB1
Schütz, LF1
Fonseca, MA1
Zhang, XF1
Zhang, CH1
Zheng, J1
Li, LX1
Geng, TQ1
Zhang, Y1
Grossi, IM1
Foster, SA1
Gainey, MR1
Krile, RT1
Dunn, JA1
Brundage, T1
Khouri, JM1
Coletta, RR1
Jorge, AA1
D'Alva, CB1
Pinto, EM1
Billerbeck, AE1
Pachi, PR1
Longui, CA1
Garcia, RM1
Boguszewski, M1
Arnhold, IJ1
Mendonca, BB1
Costa, EM1
Ying, B2
Tollefson, AE2
Spencer, JF2
Balakrishnan, L1
Dewhurst, S1
Capella, C1
Buller, RM2
Toth, K2
Wold, WS2
Smee, DF6
Wong, MH4
Russell, A1
Ennis, J1
Turner, JD1
Lin, PY1
Lin, YL1
Huang, CC1
Chen, SS1
Liu, YW1
Doney, A1
Fischer, B1
Frew, D1
Cumming, A1
Flavell, DM1
World, M1
Montgomery, HE1
Boyle, D1
Morris, A1
Palmer, CN1
EVANS, JS1
BOSTWICK, L1
MENGEL, GD1
Bravo, FJ1
Bourne, N1
Schleiss, MR1
Bernstein, DI1
Bailey, KW4
Beadle, JR1
Hostetler, KY1
Sidwell, RW5
Rietveld, I1
Janssen, JA1
van Rossum, EF1
Houwing-Duistermaat, JJ1
Rivadeneira, F1
Hofman, A1
Pols, HA1
van Duijn, CM1
Lamberts, SW1
Lapointe, R1
Létourneau, R1
Steward, W1
Hawkins, RE1
Batist, G1
Vincent, M1
Whittom, R1
Eatock, M1
Jolivet, J2
Moore, M1
Sparreboom, A1
Wolff, AC1
Mathijssen, RH1
Chatelut, E1
Rowinsky, EK1
Verweij, J1
Baker, SD1
Gowen, BB1
Wandersee, MK1
Skirpstunas, RT1
Baldwin, TJ1
Hoopes, JD1
Liekens, S1
Andrei, G1
Vandeputte, M1
De Clercq, E1
Neyts, J1
Bolger, G1
Lapeyre, N1
Rhéaume, M1
Kibler, P1
Bousquet, C1
Garneau, M1
Cordingley, M1
Weitman, S1
Marty, J1
Locas, C1
Von Hoff, DD1
Doerksen, T1
Benoit, G1
Trasler, JM1
Redondo, P1
Idoate, M1
Galofré, JC1
Solano, T1
Bray, M1
Martinez, M1
Kefauver, D1
West, M1
Roy, C1
Zia, S1
Hyde, DM1
Giri, SN1
Black, DL1
Marks, TA3
Branstetter, DG1
Kirton, KT1
Gray, JE1
Larsen, ER1
Fast, PE1
Hamilton, RD1
Poppe, SM2
Renis, HE1
Randerath, K1
Lu, LJ1
Li, D1
Schönebeck, J1
Polak, A1
Fernex, M1
Scholer, HJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of Folates in the Care of the Male Infertility[NCT01407432]Phase 3162 participants (Actual)Interventional2011-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for cytosine and Body Weight

ArticleYear
Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Body Weight; Cytosine; Dioxolanes; Disease Progression; Female;

2005

Other Studies

31 other studies available for cytosine and Body Weight

ArticleYear
Sperm DNA 5-methyl cytosine and RNA N6-methyladenosine methylation are differently affected during periods of body weight losses and body weight gain of young and mature breeding bulls.
    Journal of animal science, 2022, Feb-01, Volume: 100, Issue:2

    Topics: Adenosine; Animals; Body Weight; Breeding; Cattle; Cytosine; DNA; Male; Methylation; RNA; Semen; Spe

2022
Potential biomarkers for monitoring the toxicity of long-term exposure to atrazine in rat by metabonomic analysis.
    Xenobiotica; the fate of foreign compounds in biological systems, 2018, Volume: 48, Issue:3

    Topics: Animals; Atrazine; Biomarkers; Blood Chemical Analysis; Body Weight; Chromatography, Liquid; Cytosin

2018
Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
    Antiviral research, 2017, Volume: 143

    Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Body Temperature; Body Weigh

2017
Insulin-like growth factor 1 gene (CA)n repeats and a variable number of tandem repeats of the insulin gene in Brazilian children born small for gestational age.
    Clinics (Sao Paulo, Brazil), 2013, Volume: 68, Issue:6

    Topics: Adenosine; Birth Weight; Blood Glucose; Body Height; Body Weight; Brazil; Cytosine; Female; Humans;

2013
Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Body Weight; Cell Line, Tum

2014
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
    Antiviral research, 2014, Volume: 112

    Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line;

2014
Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Adenoviridae; Administration, Intranasal; Animals; Body Weight; Cidofovir; Cytosine; Female; Genetic

2011
Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.
    Toxicology and applied pharmacology, 2012, Feb-15, Volume: 259, Issue:1

    Topics: Animals; Antioxidants; Arsenites; Blotting, Western; Body Weight; Butylhydroxybutylnitrosamine; Coca

2012
Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.
    BMC genetics, 2002, Nov-13, Volume: 3

    Topics: Adult; Alanine; Amino Acid Substitution; Body Mass Index; Body Weight; Cytosine; Diabetes Mellitus,

2002
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    Biochemical pharmacology, 1964, Volume: 13

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia;

1964
An animal model of neonatal cytomegalovirus infection.
    Antiviral research, 2003, Volume: 60, Issue:1

    Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytomegalovirus; Cytomegalovirus In

2003
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:5

    Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; He

2004
A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.
    Clinical endocrinology, 2004, Volume: 61, Issue:2

    Topics: Adenosine; Aged; Alleles; Body Height; Body Weight; Cohort Studies; Cytosine; Female; Homozygote; Hu

2004
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Oct-20, Volume: 25, Issue:30

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Mass Index; Body

2007
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:4

    Topics: Administration, Intranasal; Animals; Antiviral Agents; Body Weight; Chemokines; Cidofovir; Cowpox; C

2008
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
    Cancer research, 1998, Jun-15, Volume: 58, Issue:12

    Topics: Animals; Antiviral Agents; Body Weight; Brain Neoplasms; Cidofovir; Cytosine; Hemangioma; Incidence;

1998
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
    Antiviral research, 1999, Dec-31, Volume: 44, Issue:3

    Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir

1999
The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4

    Topics: Animals; Antineoplastic Agents; Body Weight; Cytosine; Deoxycytidine; Dioxolanes; Dose-Response Rela

2000
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
    Antiviral chemistry & chemotherapy, 2000, Volume: 11, Issue:4

    Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox v

2000
Deoxyribonucleic acid hypomethylation of male germ cells by mitotic and meiotic exposure to 5-azacytidine is associated with altered testicular histology.
    Endocrinology, 2000, Volume: 141, Issue:9

    Topics: Animals; Apoptosis; Azacitidine; Blotting, Western; Body Weight; Cell Separation; Cytosine; DNA; DNA

2000
Cidofovir inhibits growth of B16 melanoma cells in vivo.
    The British journal of dermatology, 2000, Volume: 143, Issue:4

    Topics: Animals; Antineoplastic Agents; Body Weight; Cidofovir; Cytosine; Dose-Response Relationship, Drug;

2000
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
    Antiviral research, 2001, Volume: 52, Issue:1

    Topics: Administration, Intranasal; Animals; Antiviral Agents; Blood Gas Monitoring, Transcutaneous; Body We

2001
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
    Antiviral research, 2002, Volume: 54, Issue:3

    Topics: Administration, Inhalation; Aerosols; Animals; Antiviral Agents; Body Weight; Bronchopneumonia; Cido

2002
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Antiviral research, 2002, Volume: 54, Issue:2

    Topics: Animals; Antiviral Agents; Area Under Curve; Body Weight; Chlorocebus aethiops; Cidofovir; Cowpox; C

2002
Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
    Pharmacology & toxicology, 1992, Volume: 71, Issue:1

    Topics: Animals; Bleomycin; Body Weight; Bronchoalveolar Lavage Fluid; Collagen; Cricetinae; Cytosine; Disea

1992
Reversal of bropirimine developmental toxicity with progesterone.
    Toxicology and applied pharmacology, 1991, Mar-15, Volume: 108, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Body Weight; Cytosine; Embryo, Mammalian; Fe

1991
Orally induced adjuvant-like arthritis in the rat.
    Toxicologic pathology, 1985, Volume: 13, Issue:4

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Arthritis; Arthritis, Experimental; Body Weigh

1985
Bropirimine-induced embryolethality after oral administration to the pregnant rat.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1989, Volume: 13, Issue:1

    Topics: Administration, Oral; Animals; Body Weight; Cytosine; Embryo, Mammalian; Female; Gestational Age; In

1989
A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver.
    Carcinogenesis, 1988, Volume: 9, Issue:10

    Topics: 2-Acetylaminofluorene; 5-Methylcytosine; Adenosine Triphosphate; Animals; Body Weight; Cytosine; DNA

1988
Developmental toxicity of bropirimine in rats after oral administration.
    Teratology, 1988, Volume: 38, Issue:1

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Cyto

1988
Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function.
    Chemotherapy, 1973, Volume: 18, Issue:6

    Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Blood Platelets; Body Weight; Creatinine; Cyto

1973